Moreover, Cardamonin suppresses SETDB1 and inhibits BC cell growth while also downregulating BC inflammatory mediators that are tied to increased aggressiveness, chemotherapy resistance, poor patient survival and stem cell phenotypes [88]. This evidence concerns the gene SETDB1 and breast cancer.